What are the steps, drugs, and dosing for rapid sequence intubation (RSI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Rapid Sequence Intubation: Steps, Drugs, and Dosing

Core Medication Regimen

Administer a sedative-hypnotic induction agent (etomidate 0.3 mg/kg IV or ketamine 1-2 mg/kg IV) immediately followed by a neuromuscular blocking agent (succinylcholine 1-1.5 mg/kg IV or rocuronium 0.9-1.2 mg/kg IV) to facilitate rapid sequence intubation. 1, 2


Step-by-Step RSI Protocol

Step 1: Preparation and Preoxygenation

  • Position the patient in semi-Fowler position (head and trunk inclined) to improve first-pass success and reduce aspiration risk 1, 2
  • Preoxygenate for 3-5 minutes using one of the following methods based on patient condition 1:
    • High-flow nasal oxygen (HFNO) when challenging laryngoscopy is anticipated 1, 2
    • Noninvasive positive pressure ventilation (NIPPV) in patients with severe hypoxemia (PaO2/FiO2 < 150) 1, 2
    • Standard face mask with 100% oxygen for cooperative patients 1
  • Consider nasogastric tube decompression in patients at high risk for regurgitation of gastric contents 1
  • Have vasopressors immediately available as even hemodynamically stable agents can cause transient hypotension 2, 3

Step 2: Pretreatment (Optional - 3 Minutes Before Induction)

Pretreatment medications have largely fallen out of favor due to limited evidence, but may be considered in select scenarios 4, 5:

  • Atropine 0.02 mg/kg (minimum 0.1 mg, maximum 1 mg) before succinylcholine in pediatric patients to prevent bradycardia 1
  • Fentanyl or lidocaine for patients with elevated intracranial pressure (though evidence is limited) 5, 6

Step 3: Induction Agent Administration

Select ONE of the following induction agents 1, 2:

Etomidate (Preferred for Hemodynamic Instability)

  • Dose: 0.3 mg/kg IV 1, 2, 3
  • Onset: 30-60 seconds 5
  • Advantages: Most hemodynamically stable option, minimal effect on blood pressure 2, 3
  • Disadvantages: Transient adrenal suppression (do NOT give corticosteroids to counteract this) 1, 2
  • Special consideration: May cause less hypotension than ketamine in shock/sepsis patients 4

Ketamine (Alternative First-Line Agent)

  • Dose: 1-2 mg/kg IV (use 1 mg/kg in cardiovascularly compromised patients) 2, 7
  • Onset: 45-60 seconds 5
  • Advantages: Sympathomimetic properties maintain hemodynamic stability, preserves respiratory drive 2, 7
  • Disadvantages: May paradoxically cause hypotension in patients with depleted catecholamine stores 2
  • Preferred over etomidate in pediatric septic shock 2

Propofol (Use with Caution)

  • Dose: 2-6 mg/kg IV (reduce dose if other sedatives given) 1
  • Warnings: Causes vasodilation and decreased cardiac output; avoid in cardiovascular dysfunction or volume depletion 1

Step 4: Neuromuscular Blocking Agent (Immediately After Induction)

Critical: The sedative-hypnotic MUST be administered before the NMBA to prevent awareness during paralysis 1, 2, 3

Select ONE of the following NMBAs 1, 2:

Succinylcholine (First-Line When No Contraindications)

  • Dose: 1-1.5 mg/kg IV (or 4 mg/kg IM if no IV access) 1, 7
  • Onset: 30-45 seconds IV, 3-5 minutes IM 1
  • Duration: 5-10 minutes 1
  • Advantages: Fastest onset, shortest duration 1, 4
  • Absolute contraindications 1:
    • Malignant hyperthermia history
    • Severe burns/crush injury (>24-48 hours old)
    • Spinal cord injury (>24-48 hours old)
    • Neuromuscular disease or myopathy
    • Hyperkalemia risk (particularly boys <9 years old)

Rocuronium (When Succinylcholine Contraindicated)

  • Dose: 0.9-1.2 mg/kg IV for RSI 1, 2, 8
    • Standard intubation dose: 0.6 mg/kg provides intubation in median 1 minute 8
    • RSI dose: 1.0-1.2 mg/kg provides optimal conditions in <2 minutes 2, 8
  • Onset: 60-90 seconds at RSI doses 2, 8
  • Duration: 45-90 minutes (dose-dependent) 1
  • Advantages: No hyperkalemia risk, may be safer in traumatic brain injury 3
  • Critical consideration: Have sugammadex available for reversal in "can't intubate, can't ventilate" scenarios 2

Vecuronium (Not Recommended for RSI)

  • Dose: 0.2 mg/kg for intubation 1
  • Onset: 2 minutes (too slow for RSI) 1
  • Duration: 45-90 minutes 1
  • Not preferred for RSI due to slower onset 1

Step 5: Intubation Timing

  • Wait 45-60 seconds after medication administration before attempting intubation 2, 8
  • For rocuronium, wait at least 60 seconds or use peripheral nerve stimulator to confirm adequate blockade 2
  • Most patients achieve intubating conditions within 2 minutes 8

Step 6: Post-Intubation Management

  • Immediately initiate continuous sedation and analgesia to prevent awareness 2, 3
  • Apply at least 5 cmH2O PEEP after intubation 7
  • Consider recruitment maneuver to improve oxygenation 7

Special Population Considerations

Traumatic Brain Injury

  • Preferred regimen: Etomidate 0.3 mg/kg + rocuronium 0.9-1.2 mg/kg 3
  • Rocuronium may be safer than succinylcholine (which can increase ICP and cause hyperkalemia) 3
  • Maintain cerebral perfusion pressure by having vasopressors ready 3

Pediatric Patients

  • Succinylcholine: 1-2 mg/kg IV (2 mg/kg for infants <6 months) 1
  • Always give atropine 0.02 mg/kg before succinylcholine to prevent bradycardia 1
  • Rocuronium: 0.6-1.2 mg/kg IV 8
  • NOT recommended for rapid sequence intubation in pediatric patients per FDA 8
  • In pediatric septic shock: Use ketamine, NOT etomidate 2

Obese Patients

  • Dose all medications based on actual body weight, NOT ideal body weight 8
  • Dosing by ideal body weight results in longer time to maximum block and shorter clinical duration 8

Obstetric/Cesarean Section

  • Rocuronium is NOT recommended for rapid sequence induction in Cesarean section 8
  • Poor intubating conditions occurred in 5 of 13 women when lower thiopental doses were used 8

Critical Pitfalls and How to Avoid Them

Pitfall 1: Administering NMBA Before Induction Agent

  • Consequence: Awareness during paralysis occurs in 2.6% of ED intubations 2, 3
  • Solution: ALWAYS give sedative-hypnotic first, then immediately follow with NMBA 1, 2, 3

Pitfall 2: Inadequate Preoxygenation

  • Consequence: Rapid desaturation during apneic period 1
  • Solution: Use semi-Fowler positioning and appropriate preoxygenation method (HFNO for difficult airways, NIPPV for severe hypoxemia) 1, 2

Pitfall 3: Using Succinylcholine in Contraindicated Patients

  • Consequence: Life-threatening hyperkalemia and cardiac arrest 1
  • Solution: Screen for burns, crush injuries, spinal cord injuries, neuromuscular disease before selecting succinylcholine; if present, use rocuronium 1, 7

Pitfall 4: Inadequate Rocuronium Dosing for RSI

  • Consequence: Delayed onset, inadequate intubating conditions 8
  • Solution: Use 0.9-1.2 mg/kg for RSI, NOT the standard 0.6 mg/kg intubation dose 2, 8

Pitfall 5: Forgetting Post-Intubation Sedation

  • Consequence: Patient awareness and distress, especially with longer-acting rocuronium 2
  • Solution: Immediately initiate continuous sedation/analgesia after successful intubation; consider clinical pharmacist involvement or protocolized post-intubation sedation 3

Pitfall 6: Inadequate Preparation for Hemodynamic Instability

  • Consequence: Cardiovascular collapse during induction 2, 3
  • Solution: Have vasopressors drawn up and ready before starting RSI; consider push-dose pressors 2, 3

Medication Administration Compatibility

Flush IV line with saline before administering rocuronium or vecuronium to avoid precipitation and IV obstruction 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Rapid Sequence Intubation Medication Regimen

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Rapid Sequence Intubation Protocol for Severe Traumatic Brain Injury

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Rapid-sequence intubation and the role of the emergency department pharmacist.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2011

Guideline

Rapid Sequence Intubation with Succinylcholine, Ketamine, and Midazolam

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.